Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | -4.93% | -2.30% | -36.34% |
Financials (USD)
Sales 2024 * | 262M | Sales 2025 * | 357M | Capitalization | 253M |
---|---|---|---|---|---|
Net income 2024 * | -69M | Net income 2025 * | -20M | EV / Sales 2024 * | 1.99 x |
Net Debt 2024 * | 268M | Net Debt 2025 * | 286M | EV / Sales 2025 * | 1.51 x |
P/E ratio 2024 * |
-4.06
x | P/E ratio 2025 * |
-20.7
x | Employees | 306 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.92% |
Latest transcript on Coherus BioSciences, Inc.
1 day | -4.93% | ||
1 week | -2.30% | ||
Current month | +8.16% | ||
1 month | -14.17% | ||
3 months | -19.08% | ||
6 months | +32.50% | ||
Current year | -36.34% |
Managers | Title | Age | Since |
---|---|---|---|
Denny Lanfear
CEO | Chief Executive Officer | 68 | 10-08-31 |
Bryan Mcmichael
DFI | Director of Finance/CFO | 46 | 21-02-28 |
Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Stolper
BRD | Director/Board Member | 52 | 21-01-04 |
Mats Wahlström
BRD | Director/Board Member | 70 | 11-12-31 |
Ali Satvat
BRD | Director/Board Member | 46 | 14-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 2.23 | -0.89% | 1,247,098 |
24-05-07 | 2.25 | +1.35% | 656,324 |
24-05-06 | 2.22 | -2.20% | 1,302,068 |
24-05-03 | 2.27 | +4.61% | 1,527,524 |
24-05-02 | 2.17 | +5.34% | 993,867 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.34% | 253M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- CHRS Stock